NLS PHARMACEUTICS AG

Insiders NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Market Closed - Nasdaq Other stock markets 01:30:00 28/06/2024 am IST			5-day change	1st Jan Change
0.24 ^USD	+31.43%		+28.41%	-59.32%

27/06	Sector Update: Health Care Stocks Slipping Late Afternoon	MT
27/06	Sector Update: Health Care	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors	09/04	CI
NLS Pharmaceutics Ltd. Approves Board Appointments	01/23/01	CI
NLS Pharmaceutics AG Announces Executive Changes	25/23/25	CI
NLS Pharmaceutics Ltd. Announces the Resignation of Chad Hellmann as Chief Financial Officer	06/23/06	CI
NLS Pharmaceutics Ltd. Pharmaceutics Announces Launch of Paid for Named Patient Program with Mazindol ER for Idiopathic Hypersomnia, a Serious Sleep Disorder with No Approved Treatment Options in Europe	23/22/23	CI
NLS Pharmaceutics Ltd. Announces Management Changes	08/22/08	CI
NLS Pharmaceutics Ltd. Appoints Eric Konofal as Chief Scientific Officer	19/21/19	CI
NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer	05/21/05	CI
NLS Pharmaceutics AG Announces Resignation of Pascal Brenneisen as A Member of the Board of Director	01/21/01	CI
NLS Pharmaceutics Ltd. Approves Board and Committee Appointments	03/21/03	CI
NLS Pharmaceutics Ltd. Appoints Sandy Eisen as Chief Medical Officer	03/19/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer